A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India

por Sharma, Hitt, Marthak, Kiran, Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Desai, Shivani, Patel, Akash, Rao, Harish, Gairola, Sunil, Shaligram, Umesh
Publicado 2023

A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddler...

por Sharma, Hitt, Lalwani, Sanjay, Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Palkar, Sonali, Hanumante, Neeta, Gokhale, Shilpa, Ks, Jaganathan, Kumar, Rakesh, Sharma, Inderjit, Gairola, Sunil
Publicado 2022

A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults

por Sharma, Hitt, Anil, K., Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Desai, Shivani, Madhusudhan, R.L., Patel, Jaya, Eswaraiah, Anand, Rao, Harish, Gairola, Sunil, Shaligram, Umesh
Publicado 2023

Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin

por Rathod, Vishal, Kadam, Laxmikant, Gautam, Manish, Gumma, Prabhu Dasu, Marke, Kevin, Asokanathan, Cathy, Douglas-Bardsley, Alex, Hassell, Laura, Bhandare, Sachin, Gupta, Sumit, Parekh, Sameer, Pujari, Pramod, Rao, Harish, Sharma, Hitt, Shaligram, Umesh, Gairola, Sunil
Publicado 2023